1983
DOI: 10.1016/0021-9681(83)90012-7
|View full text |Cite
|
Sign up to set email alerts
|

Salivary phenytoin levels in institutionalized epileptics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

1984
1984
2006
2006

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…As with serum concentrations there is no clear picture. For phenytoin, some studies have reported that salivary concentrations are positively correlated with gingival overgrowth (Babcock & Nelson 1964, Conard et al 1974, Hassell et al 1983), whilst others have failed to confirm such a relationship (Ball et al 1996, Dahllof & Modeer 1986, Modeer & Dahllof 1987. It is possible that the concentration of phenytoin or its major metabolite (HPPH) present in saliva are not representative of those present at the site of action, that is, the gingival tissue itself.…”
Section: Drug Variablesmentioning
confidence: 99%
“…As with serum concentrations there is no clear picture. For phenytoin, some studies have reported that salivary concentrations are positively correlated with gingival overgrowth (Babcock & Nelson 1964, Conard et al 1974, Hassell et al 1983), whilst others have failed to confirm such a relationship (Ball et al 1996, Dahllof & Modeer 1986, Modeer & Dahllof 1987. It is possible that the concentration of phenytoin or its major metabolite (HPPH) present in saliva are not representative of those present at the site of action, that is, the gingival tissue itself.…”
Section: Drug Variablesmentioning
confidence: 99%
“…As mentioned before, drug‐induced gingival overgrowth is thought to be a multifactorial model. Inflammatory cytokines, growth factors, pharmacokinetic variables, periodontal variables, and genetic factors might have possible roles in this model 10‐26 . Thus, newer molecular approaches are needed to clearly establish the pathogenesis of drug‐induced gingival enlargement.…”
Section: Discussionmentioning
confidence: 99%
“…Inflammatory cytokines, growth factors, pharmacokinetic variables, periodontal variables, and genetic factors might have possible roles in this model. [10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] Thus, newer molecular approaches are needed to clearly establish the pathogenesis of druginduced gingival enlargement.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations